cGxP.wire https://validator.w3.org/feed/docs/rss2.html AstraZeneca Completes $2B Investment in Summit Therapeutics Aptar Pharma Launches Premia Precision Quality Standard BridgeBio Pharma Advances BBP-418 in LGMD2I/R9 Crescent Biopharma Gains FDA Clearance for CR-002 IND Pharvaris Real-World HAE Analysis Highlights Treatment Gaps Teva Presents New Ecopipam Data in Tourette Syndrome Stoke Aligns With FDA on Zorevunersen NDA Alterity Presents New ATH434 Phase 2 Data in MSA Rezolute Receives FDA Pre-BLA Recommendation for Ersodetug Sernova and Seraxis Close $11.2M Financing for BetaNova Clear Scientific Reports Positive Phase 2 Results for CS-1103 Resero Bio Advances RNA Liquid Biopsy for Bladder Cancer Aravax to Report PVX108 Phase 2 Peanut Allergy Data CSL and Alentis Partner on Lixudebart for Rare Diseases Vaxcyte Reports Positive Phase 3 VAX-31 Results Orano Med Opens Europe’s First Lead-212 ATLab Surrozen Gains FDA Clearance for SZN-8141 in DME Saros Therapeutics Secures $2M Award for Cancer Immunotherapy Teva Highlights Ecopipam Mechanism in Tourette Syndrome AnnJi Advances AJ201 Into Phase 3 SBMA Trial Aroa Biosurgery Reports Strong Symphony Results in DFUs Abogen and Novartis Forge $7.2B RNA Therapeutics Deal ABK Biomedical Advances Eye90 With New U.S. Manufacturing Facility CeleCor Wins FDA Review for Investigational Heart Attack Drug Genmab Reports Durable Rina-S Responses in Ovarian Cancer Alvotech Gains FDA Approval for Simlandi Manufacturing Capacity Antengene Advances Cos-TCE Platform With SITC 2026 Data BioMarin Reports Five-Year Data for Pompe Disease Therapy Astellas Reports VEOZAH Data Improving Menopause Symptoms XtalPi Advances Novel Hair Loss Drug Into IND-Ready Studies Autonomix Expands Patent Protection for Nerve Therapy CRISPR Therapeutics Advances Zugo-cel in Autoimmune Disease JCR and Italfarmaco Expand Global Hunter Syndrome Deal Biogen Litifilimab Shows Durable CLE Benefits Teknova and Pluristyx File FDA DMF for PluriFreeze Lilly and Jaypirca Expand CLL/SLL Treatment Options Banner Capital Agrees to Acquire Three Plastics Companies Marengo Reports Phase 2 Invikafusp Alfa Trial Data Bristol Myers Squibb Launches Champions in Care Movement Quotient Sciences and Acesion Advance AI Formulation Daiichi Sankyo and AstraZeneca Partner With Summit on Datroway Verastem Reports New RAMP 201 Data in Recurrent LGSOC Johnson & Johnson Reports Two-Year Icotrokinra Psoriasis Data Candel Reports 24.5-Month Survival in NSCLC Study SeaStar Medical Gains New AKI Billing Codes Akari Therapeutics Expands PH1 ADC Patent Portfolio Lundbeck Advances Movement Disorder Pipeline With New Data ViroMissile Advances IDOV-2 Phase I Trial After First Cohort Ascletis Reports Promising Weight-Loss Data for ASC36_35FDC Nexalin Technology Expands Commercial Push in South America